FI
FibroBiologics, Inc.
SEC filingPharmaceuticals · Houston, TX
Amount raised$500Ksold at filing
Total offering$500K
Investors in the raise1count reported to the SEC
FiledSep 16, 2026first sale Sep 15, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Kathleen H. RubinsDirector
Hamid A. KhojaExecutive Officer
Robert C. HoffmanDirector
Ruben A. GarciaExecutive Officer
Jason D. DavisExecutive Officer
Leigh H. SteinbergDirector
Pete O'HeeronExecutive Officer, Director
Victoria C. NiklasDirector
Richard C. CilentoDirector
Executive officers, directors and promoters as listed on the Form D.